Bio-Techne vs Hitachi: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Bio-Techne Corp (TECH)

Q3 202628 Jun – 23 Sep 2026

▲3

Bio-Techne's $73-a-share Merck buyout clears shareholder vote and antitrust review

Shareholders approve Merck KGaA buyout On September 23, 2026, Bio-Techne shareholders voted to approve the $73-per-share cash buyout by Merck KGaA. This locks in the deal price and moves the company closer to closing, so the stock should trade near $73 rather than on its own business results.
This is the latest and most important step in the buyout that now defines TECH's price.
Antitrust waiting period expires The U.S. antitrust waiting period under the Hart-Scott-Rodino Act expired on September 18, 2026. That removes a major regulatory hurdle, making it more likely the deal closes on schedule and reducing the risk that the $73 price falls through.
It is a new, concrete regulatory clearance that directly supports deal completion.
Merck KGaA confirms deal on track Merck KGaA raised its 2026 outlook on August 6 and said it still expects to close the Bio-Techne purchase by late 2026 or early 2027, with about 140 million euros in annual cost savings. A healthy buyer with a firm timeline makes the $73 payout more certain.
It shows the acquirer is financially strong and committed, which supports the deal price.
Weak quarterly sales and legal probe Bio-Techne's revenue fell 1.5% to $311.4 million, missing estimates, and a law firm is investigating whether the board handled the buyout fairly. These are minor now because the $73 cash deal caps the stock, but they could matter if the deal breaks.
It gives the fair counterweight: the company's own results are soft and the deal faces a legal review.

August 202628 Jun – 23 Sep 2026

▲3

Bio-Techne's $73-a-share Merck buyout clears shareholder vote and antitrust review

Shareholders approve Merck KGaA buyout On September 23, 2026, Bio-Techne shareholders voted to approve the $73-per-share cash buyout by Merck KGaA. This locks in the deal price and moves the company closer to closing, so the stock should trade near $73 rather than on its own business results.
This is the latest and most important step in the buyout that now defines TECH's price.
Antitrust waiting period expires The U.S. antitrust waiting period under the Hart-Scott-Rodino Act expired on September 18, 2026. That removes a major regulatory hurdle, making it more likely the deal closes on schedule and reducing the risk that the $73 price falls through.
It is a new, concrete regulatory clearance that directly supports deal completion.
Merck KGaA confirms deal on track Merck KGaA raised its 2026 outlook on August 6 and said it still expects to close the Bio-Techne purchase by late 2026 or early 2027, with about 140 million euros in annual cost savings. A healthy buyer with a firm timeline makes the $73 payout more certain.
It shows the acquirer is financially strong and committed, which supports the deal price.
Weak quarterly sales and legal probe Bio-Techne's revenue fell 1.5% to $311.4 million, missing estimates, and a law firm is investigating whether the board handled the buyout fairly. These are minor now because the $73 cash deal caps the stock, but they could matter if the deal breaks.
It gives the fair counterweight: the company's own results are soft and the deal faces a legal review.

Latest28 Jun – 23 Sep 2026

▲3

Bio-Techne's $73-a-share Merck buyout clears shareholder vote and antitrust review

Shareholders approve Merck KGaA buyout On September 23, 2026, Bio-Techne shareholders voted to approve the $73-per-share cash buyout by Merck KGaA. This locks in the deal price and moves the company closer to closing, so the stock should trade near $73 rather than on its own business results.
This is the latest and most important step in the buyout that now defines TECH's price.
Antitrust waiting period expires The U.S. antitrust waiting period under the Hart-Scott-Rodino Act expired on September 18, 2026. That removes a major regulatory hurdle, making it more likely the deal closes on schedule and reducing the risk that the $73 price falls through.
It is a new, concrete regulatory clearance that directly supports deal completion.
Merck KGaA confirms deal on track Merck KGaA raised its 2026 outlook on August 6 and said it still expects to close the Bio-Techne purchase by late 2026 or early 2027, with about 140 million euros in annual cost savings. A healthy buyer with a firm timeline makes the $73 payout more certain.
It shows the acquirer is financially strong and committed, which supports the deal price.
Weak quarterly sales and legal probe Bio-Techne's revenue fell 1.5% to $311.4 million, missing estimates, and a law firm is investigating whether the board handled the buyout fairly. These are minor now because the $73 cash deal caps the stock, but they could matter if the deal breaks.
It gives the fair counterweight: the company's own results are soft and the deal faces a legal review.

Q2 202625 Jun – 26 Jun 2026

▲1▼1

Merck KGaA to buy Bio-Techne for $73/share in $11.3B cash deal

Merck KGaA acquisition at $73/share cash Germany's Merck KGaA agreed to acquire Bio-Techne for $73 per share in cash, a 36% premium to its recent average price. This puts a firm floor under the stock near the deal price and is the main reason shares jumped about 20%.
This is the single new event that explains the stock's move and future path.
Deal completion risk and timeline The deal needs regulatory approvals and a shareholder vote, and is expected to close in late 2026 or early 2027. Until then, the stock may trade below $73 if investors worry the deal could fall through, but the agreed price limits big downside.
It is the main counterweight: the deal is not yet final, so the premium is not guaranteed.
Weak underlying quarterly revenue Bio-Techne's latest quarterly revenue fell 1.5% to $311.4 million and missed expectations. This weak operating performance is now less important because the company is being bought, but it shows why the standalone business was struggling.
It explains the weak standalone backdrop that the buyout overrides, giving a fair picture.

June 202625 Jun – 26 Jun 2026

▲1▼1

Merck KGaA to buy Bio-Techne for $73/share in $11.3B cash deal

Merck KGaA acquisition at $73/share cash Germany's Merck KGaA agreed to acquire Bio-Techne for $73 per share in cash, a 36% premium to its recent average price. This puts a firm floor under the stock near the deal price and is the main reason shares jumped about 20%.
This is the single new event that explains the stock's move and future path.
Deal completion risk and timeline The deal needs regulatory approvals and a shareholder vote, and is expected to close in late 2026 or early 2027. Until then, the stock may trade below $73 if investors worry the deal could fall through, but the agreed price limits big downside.
It is the main counterweight: the deal is not yet final, so the premium is not guaranteed.
Weak underlying quarterly revenue Bio-Techne's latest quarterly revenue fell 1.5% to $311.4 million and missed expectations. This weak operating performance is now less important because the company is being bought, but it shows why the standalone business was struggling.
It explains the weak standalone backdrop that the buyout overrides, giving a fair picture.

25 Jun – 26 Jun 2026

▲1▼1

Merck KGaA to buy Bio-Techne for $73/share in $11.3B cash deal

Merck KGaA acquisition at $73/share cash Germany's Merck KGaA agreed to acquire Bio-Techne for $73 per share in cash, a 36% premium to its recent average price. This puts a firm floor under the stock near the deal price and is the main reason shares jumped about 20%.
This is the single new event that explains the stock's move and future path.
Deal completion risk and timeline The deal needs regulatory approvals and a shareholder vote, and is expected to close in late 2026 or early 2027. Until then, the stock may trade below $73 if investors worry the deal could fall through, but the agreed price limits big downside.
It is the main counterweight: the deal is not yet final, so the premium is not guaranteed.
Weak underlying quarterly revenue Bio-Techne's latest quarterly revenue fell 1.5% to $311.4 million and missed expectations. This weak operating performance is now less important because the company is being bought, but it shows why the standalone business was struggling.
It explains the weak standalone backdrop that the buyout overrides, giving a fair picture.

Hitachi, Ltd. (6501.JP)

Q3 202617 Jun – 16 Sep 2026

▲3▼1

Hitachi lifted profit outlook on AI data-center power demand

AI data-center power demand boosts profit forecast Hitachi raised its full-year net profit forecast 12.2% to ¥900bn, driven by strong demand for power equipment used in AI data centers. Q1 adjusted operating profit jumped 39.5%, with Digital Systems & Services leading at ¥450bn and Energy profit up 65%.
This is the main new positive force behind the stock this quarter.
Expanded AI partnerships and new services Hitachi expanded its partnership with OpenAI, joined Nvidia's physical AI coalition, launched a crypto anti-money-laundering service, and saw growing demand for rail batteries. These moves position Hitachi in fast-growing AI and digital markets.
New strategic partnerships and services that could drive future growth.
Hitachi Energy invests in US transformer plant Hitachi Energy committed $528m to a Mississippi transformer plant and signed an MoU with Mission Critical Group for data-center power equipment. This expands US capacity to meet AI-driven electricity demand.
Significant capital investment to capture growing US power infrastructure demand.
Risks: AI reliance, execution, and cash outlay Q1 net profit dipped slightly. Risks include heavy reliance on AI-driven demand, execution challenges in new partnerships and markets, and the Mississippi plant's cash outlay with payoff only from 2029.
These are real counterweights that could pressure the stock if they materialize.

August 202613 Aug – 16 Sep 2026

▲4

Hitachi rides AI power and data-center demand with record profits and US expansion

Nvidia physical AI coalition Hitachi joined Nvidia's physical AI coalition, building robots and industrial AI on Nvidia's platforms. This ties Hitachi to Japan's huge government-backed AI robotics push, a long-term source of orders for its digital and industrial businesses, supporting the shares.
New partnership signals durable AI-driven demand for Hitachi.
Digital unit leads profit Full-year results show Hitachi's Digital Systems & Services unit earned 450 billion yen, the most of any segment, with a 16.3% margin, while Energy profit jumped 65%. Strong, higher-margin earnings underpin the stock and justify its recovery toward the 5,400 yen range.
Earnings power is the core fundamental driver of the share price.
US transformer factory Hitachi Energy will spend $528 million (about 82 billion yen) on a Mississippi transformer plant, part of a $1.5 billion US expansion, to meet AI-driven electricity demand. It adds long-term capacity and revenue, though the cash outlay and 2029 start mean payoff is years away.
Major capex shows Hitachi positioning for AI power demand.
Data-center partnership Hitachi signed an MoU with Mission Critical Group to jointly build and sell data-center power and modular equipment, combining Hitachi Energy and digital tech with MCG's 18 US factories. It widens Hitachi's reach into a market growing about 20% a year, supporting future orders.
New partnership expands Hitachi's data-center addressable market.

Latest13 Aug – 16 Sep 2026

▲4

Hitachi rides AI power and data-center demand with record profits and US expansion

Nvidia physical AI coalition Hitachi joined Nvidia's physical AI coalition, building robots and industrial AI on Nvidia's platforms. This ties Hitachi to Japan's huge government-backed AI robotics push, a long-term source of orders for its digital and industrial businesses, supporting the shares.
New partnership signals durable AI-driven demand for Hitachi.
Digital unit leads profit Full-year results show Hitachi's Digital Systems & Services unit earned 450 billion yen, the most of any segment, with a 16.3% margin, while Energy profit jumped 65%. Strong, higher-margin earnings underpin the stock and justify its recovery toward the 5,400 yen range.
Earnings power is the core fundamental driver of the share price.
US transformer factory Hitachi Energy will spend $528 million (about 82 billion yen) on a Mississippi transformer plant, part of a $1.5 billion US expansion, to meet AI-driven electricity demand. It adds long-term capacity and revenue, though the cash outlay and 2029 start mean payoff is years away.
Major capex shows Hitachi positioning for AI power demand.
Data-center partnership Hitachi signed an MoU with Mission Critical Group to jointly build and sell data-center power and modular equipment, combining Hitachi Energy and digital tech with MCG's 18 US factories. It widens Hitachi's reach into a market growing about 20% a year, supporting future orders.
New partnership expands Hitachi's data-center addressable market.

July 202617 Jun – 30 Jul 2026

▲3▼1

Hitachi lifts profit outlook on AI demand, expands tech partnerships

AI partnerships and recognition Hitachi expanded its OpenAI partnership for banking and cybersecurity, earned WEF recognition for its Oklahoma plant, and joined Nvidia's physical AI coalition, strengthening its AI credentials.
These moves highlight Hitachi's growing AI ecosystem and potential for future revenue.
Raised profit forecast on AI data-center power demand Hitachi raised its full-year net profit forecast by 12.2% to ¥900bn, driven by AI data-center power demand, and reported Q1 adjusted operating profit up 39.5%.
This directly reflects improved financial performance and outlook, a key driver for the stock.
New services and market expansion Hitachi announced a new crypto AML service and saw expanded rail battery demand, indicating diversification into new areas and additional revenue streams.
These initiatives show Hitachi's efforts to broaden its business beyond core segments.
Q1 net profit dip and execution risks Despite overall strength, Q1 net profit declined slightly, and reliance on AI-driven demand plus execution challenges in new partnerships and markets temper the positive outlook.
This provides a balanced view by highlighting potential headwinds that could affect future performance.

20 Jul – 30 Jul 2026

▲4

Hitachi lifts profit outlook on AI data-center power demand

Hitachi raises full-year profit forecast on AI data-center power demand Hitachi lifted its full-year net profit forecast to 900 billion yen, up 12.2%, and adjusted operating profit to 1.408 trillion yen. The upgrade is driven by strong sales of power transmission equipment used in AI data centers, showing its energy business is a real growth engine.
This is the main new event that directly answers why the stock is moving now.
Q1 profit dips slightly but core operating profit jumps 39.5% First-quarter net profit slipped 1.4% to 189.45 billion yen, but adjusted operating profit surged 39.5% to 294.2 billion yen and revenue rose to 2.71 trillion yen. The profit dip is minor; the strong underlying operating performance supports the upbeat outlook.
It shows the earnings quality behind the raised forecast, which investors care about.
New anti-money laundering service for crypto assets Hitachi will launch an AML monitoring service in October for crypto, stablecoins, and NFTs, after a proof-of-concept with 17 financial and crypto firms. This opens a new revenue stream in digital-asset compliance, a fast-growing area, and shows Hitachi's ability to turn regulation into business.
It is a new product launch that adds a future growth driver beyond the current earnings story.
Rail battery expansion signals strong train orders Turntide is expanding battery production because of demand from Hitachi Rail, supporting hybrid trains built in the UK. This points to a healthy order book in Hitachi's rail business, adding to confidence in its industrial segment.
It is a fresh demand signal for Hitachi's rail unit, which is part of the overall growth picture.

17 Jun – 16 Jul 2026

▲4

Hitachi deepens AI ties with OpenAI and Nvidia, turning AI into real products

OpenAI partnership expands into legacy systems and cybersecurity Hitachi is widening its OpenAI work: joint engineer teams will use OpenAI's Codex AI to read and modernize old bank computer systems, and Hitachi gets OpenAI cyber models to defend against attacks. This makes Hitachi's AI services more valuable and opens a new market, supporting the share price.
A concrete new partnership that expands Hitachi's AI business and revenue opportunity.
Oklahoma factory wins WEF Global Lighthouse recognition Hitachi Vantara's Oklahoma storage plant was named a World Economic Forum Lighthouse factory after AI cut order-to-shipment time 77% and inventory 50%. Hitachi will fold these proven AI methods into its HMAX product suite, showing customers real results and strengthening its AI-selling story.
New proof point that Hitachi's own AI works, boosting credibility and future sales.
Hitachi joins Nvidia's physical AI push in Japan At Nvidia's Tokyo event, Hitachi said it will join the Cosmos Coalition for open physical AI models and work with Nvidia to integrate and control whole sites like factories and power plants. This positions Hitachi in the fast-growing robot-and-factory AI market, a positive for future orders.
New Nvidia partnership directly ties Hitachi to the physical AI theme investors are watching.
Intel foundry interest and Hitachi physical AI tie reinforce chip supply Reports say Google and Nvidia may use Intel's chip factories as capacity runs short, and Intel and Hitachi already announced a June collaboration on physical AI and next-generation computing. Stronger Intel foundry prospects support the hardware side of Hitachi's AI and infrastructure plans.
Links Hitachi's earlier Intel tie to a broader chip-supply story that underpins its AI hardware.